Literature DB >> 25861934

Anxiolytic-like effects of ursolic acid in mice.

André R S Colla1, Julia M Rosa1, Mauricio P Cunha1, Ana Lúcia S Rodrigues2.   

Abstract

Ursolic acid is a pentacyclic triterpenoid that possesses several biological and neuropharmacological effects including antidepressant-like activity. Anxiety disorders represent common and disability psychiatric conditions that are often associated with depressive symptoms. This work investigated the anxiolytic-like effects of ursolic acid administration in different behavioral paradigms that evaluate anxiety in mice: open field test, elevated plus maze test, light/dark box test and marble burying test. To this end, mice were administered with ursolic acid (0.1, 1 and 10mg/kg, p.o.) or diazepam (2mg/kg, p.o.), positive control, and submitted to the behavioral tests. The results show that ursolic acid (10mg/kg) elicited an anxiolytic-like effect observed by the increased total time in the center and decreased number of rearings responses in the open field test and an increased percentage of entries and total time spent in the open arms of elevated plus maze, similarly to diazepam. No significant effects of ursolic acid were shown in the light/dark box and marble burying test. These data indicate that ursolic acid exhibits anxiolytic-like effects in the open field and elevated plus maze test, but not in the light/dark box and marble burying test, showing the relevance of testing several behavioral paradigms in the evaluation of anxiolytic-like actions. Of note, the results extend the understanding on the effects of ursolic acid in the central nervous system and suggest that it may be a novel approach for the management of anxiety-related disorders.
Copyright © 2015. Published by Elsevier B.V.

Entities:  

Keywords:  Anxiety; Elevated plus maze; Open field test; Ursolic acid

Mesh:

Substances:

Year:  2015        PMID: 25861934     DOI: 10.1016/j.ejphar.2015.03.077

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  14 in total

Review 1.  Therapeutic Potential of Ursolic Acid to Manage Neurodegenerative and Psychiatric Diseases.

Authors:  Ana B Ramos-Hryb; Francis L Pazini; Manuella P Kaster; Ana Lúcia S Rodrigues
Journal:  CNS Drugs       Date:  2017-12       Impact factor: 5.749

2.  Protective Effects of Ursolic Acid Against Cytotoxicity Induced by Corticosterone: Role of Protein Kinases.

Authors:  Ana B Ramos-Hryb; Nicolle Platt; Andiara E Freitas; Isabella A Heinrich; Manuela G López; Rodrigo B Leal; Manuella P Kaster; Ana Lúcia S Rodrigues
Journal:  Neurochem Res       Date:  2019-11-11       Impact factor: 3.996

3.  In vitro effectiveness of triterpenoids and their synergistic effect with antibiotics against Staphylococcus aureus strains.

Authors:  Muhammad Hamza; Maha Nadir; Nadir Mehmood; Adeel Farooq
Journal:  Indian J Pharmacol       Date:  2016 Nov-Dec       Impact factor: 1.200

4.  Moderation of the transgenerational transference of antenatal stress-induced anxiety.

Authors:  Or Burstein; Noam Simon; Yaarit Simchon-Tenenbaum; Moshe Rehavi; Motty Franko; Alon Shamir; Ravid Doron
Journal:  Transl Psychiatry       Date:  2021-05-04       Impact factor: 6.222

5.  Biocatalysis of ursolic acid by the fungus Gliocladium roseum CGMCC 3.3657 and resulting anti-HCV activity.

Authors:  Shaobin Fu; Qingfeng Meng; Junshan Yang; Jiajia Tu; Di-An Sun
Journal:  RSC Adv       Date:  2018-05-03       Impact factor: 3.361

6.  Low doses of ketamine and guanosine abrogate corticosterone-induced anxiety-related behavior, but not disturbances in the hippocampal NLRP3 inflammasome pathway.

Authors:  Anderson Camargo; Ana Paula Dalmagro; Daiane B Fraga; Julia M Rosa; Ana Lúcia B Zeni; Manuella P Kaster; Ana Lúcia S Rodrigues
Journal:  Psychopharmacology (Berl)       Date:  2021-08-03       Impact factor: 4.530

7.  Assessment of the Anticonvulsant Potency of Ursolic Acid in Seizure Threshold Tests in Mice.

Authors:  Dorota Nieoczym; Katarzyna Socała; Piotr Wlaź
Journal:  Neurochem Res       Date:  2018-03-14       Impact factor: 3.996

8.  Evaluation of Anti-Toxoplasma gondii Effect of Ursolic Acid as a Novel Toxoplasmosis Inhibitor.

Authors:  Won Hyung Choi; In Ah Lee
Journal:  Pharmaceuticals (Basel)       Date:  2018-05-09

9.  Myelin Protection by Ursolic Acid in Cuprizone-Induced Demyelination in Mice.

Authors:  Fatemeh Honarvar; Vida Hojati; Nuredin Bakhtiari; Gholamhassan Vaezi; Mohammad Javan
Journal:  Iran J Pharm Res       Date:  2019       Impact factor: 1.696

10.  Behavioral, neuromorphological, and neurobiochemical effects induced by omega-3 fatty acids following basal forebrain cholinergic depletion in aged mice.

Authors:  Debora Cutuli; Eugenia Landolfo; Annalisa Nobili; Paola De Bartolo; Stefano Sacchetti; Doriana Chirico; Federica Marini; Luisa Pieroni; Maurizio Ronci; Marcello D'Amelio; Francesca Romana D'Amato; Stefano Farioli-Vecchioli; Laura Petrosini
Journal:  Alzheimers Res Ther       Date:  2020-11-16       Impact factor: 6.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.